Brief: Epirus Biopharmaceuticals provided written notice to terminate purchase agreement
Jan 26 (Reuters) - EPIRUS Biopharmaceuticals Inc EPRS.O : * On January 23, co provided written notice to terminate certain purchase agreement with Lincoln park capital fund, llc * Epirus biopharmaceuticals-co will not incur any early termination penalties in connection with the termination of the purchase agreement * Source text for Eikon (http://1.usa.gov/1LcGw2L) * Further company coverage EPRS.O ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on Epirus Biopharmaceuticals
See all newsBrief: Epirus Biopharmaceuticals entered settlement satisfaction amendment with Livzon Mabpharm
Brief: Jennison Associates dissolves passive stake in Epirus Biopharmaceuticals
Brief: Epirus Biopharmaceuticals enters term sheet with Zaklady Farmaceutyczne
Brief: Epirus Biopharmaceuticals announces reprioritization of pipeline
Brief: Epirus biopharmaceuticals files for non-timely 10-k - sec filing